Literature DB >> 33408018

Doxycycline as an Alternative to Azithromycin in Elderly Patients.

Alexandre Elias Malek1, Bruno P Granwehr2.   

Abstract

Entities:  

Keywords:  COVID-19; Doxycycline; Hydroxycholoroquine

Year:  2021        PMID： 33408018     DOI： 10.1016/j.ijantimicag.2020.106168

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  3 in total

1.  Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From in silico to in vitro Validation.

Authors:  Rajaiah Alexpandi; Mathieu Gendrot; Gurusamy Abirami; Océane Delandre; Isabelle Fonta; Joel Mosnier; Richard Mariadasse; Jeyaraman Jeyakanthan; Shunmugiah Karutha Pandian; Bruno Pradines; Arumugam Veera Ravi
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

2.  Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.

Authors:  Philippe Gautret; Stéphane Honoré; Jean-Christophe Lagier; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2021-01       Impact factor: 5.283

3.  Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review.

Authors:  Subhrojyoti Bhowmick; Amit Dang; B N Vallish; Sumit Dang
Journal:  Drug Saf       Date:  2021-04-16       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.